Ipamorelin vs Selank
A comprehensive, data-driven comparison of Ipamorelin (NNC 26-0161) and Selank (TP-7). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Ipamorelin NNC 26-0161 | Selank TP-7 |
|---|---|---|
| FDA Status | Category 2 (pending reclassification) | Not submitted |
| Category | Growth Hormone | Cognitive Enhancement |
| Primary Use | Growth hormone optimization | Anxiety disorders and cognitive enhancement |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $35 - $70/mo | $40 - $80/mo |
| Administration | Subcutaneous injection | Nasal spray |
| Typical Dose | 200-300mcg 2-3x daily | 2-3 drops per nostril 2-3x daily |
| Frequency | Daily | Daily |
| Mechanism | Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH release without affecting cortisol or prolactin | Synthetic peptide analog of tuftsin that modulates GABA, serotonin, and norepinephrine for anxiolytic effects |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Emerging | Moderate |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Ipamorelin is generally more affordable ($35 - $70/mo) compared to Selank ($40 - $80/mo).
- 2Ipamorelin is administered via subcutaneous injection, while Selank uses nasal spray.
- 3Selank has moderate-quality evidence, while Ipamorelin has emerging-quality evidence.
- 4They belong to different categories: Ipamorelin (Growth Hormone) vs Selank (Cognitive Enhancement).
Which Is Better For...
Ipamorelin
More budget-friendly option with lower monthly costs
Selank
Fewer commonly reported side effects
Selank
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Ipamorelin | $35 - $70/mo | Category 2 (pending reclassification) | Various research labs |
| Selank | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Ipamorelin works via Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH. Selank works via Synthetic peptide analog of tuftsin that modulates GABA, serotonin, and norepinephrine for. They differ in FDA approval status, efficacy data, and cost.
Ipamorelin typically costs $35 - $70/mo, while Selank costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Ipamorelin is not FDA-approved (Category 2 (pending reclassification)). Selank is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Ipamorelin include Injection site reactions, Increased hunger, Headache. Common side effects of Selank include Nasal irritation, Mild drowsiness, Headache. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Ipamorelin is a pentapeptide that selectively stimulates growth hormone release by mimicking ghrelin, the hunger hormone. Unlike many other GH secretagogues, ipamorelin does not significantly increase...
View Full Ipamorelin GuideSelank is a synthetic heptapeptide developed in Russia as an anxiolytic and nootropic agent. It has been shown to reduce anxiety without causing sedation or addiction, while potentially improving memo...
View Full Selank GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Ipamorelin and Selank should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.